Table 1.
Subtype assayed |
Genotype/ Antagonist |
Region | Assay | Half-time (τ) of onset (min)a | % desensitization by 300 nM nic |
---|---|---|---|---|---|
(α4β2)2β2 | α5KO | Cortex | GABA | 0.39 ± 0.04 | 56 ± 4 |
(α4β2)2β2 | α5KO/αCtxMII | Striatum | DA | 0.32 ± 0.03 | 60 ± 4 |
(α4β2)2β2 + (α4β2)2α5 |
WT | Cortex | GABA | 0.17 ± 0.06 | 48 ± 6 |
(α4β2)2β2 + (α4β2)2α5 |
α6KO | Striatum | DA | 0.18 ± 0.05 | 48 ± 11 |
(α6β2)2β3 | α4KO | Striatum | DA | 0.052 ± 0.008 | 25 ± 1 |
Half-times of onset should be considered estimates.